Forges-les-Bains, France

Alain Andre Champseix

This inventor holds 1 USPTO granted patent. Top assignee: Mar-Pha Societe D'etudes Et D'exploitation De Marques. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Alain Andre Champseix

Introduction

Alain Andre Champseix, an inventive mind based in Forges les Bains Limours, France, has made noteworthy contributions to the field of pharmacology. With a patent to his name, Champseix has focused on the development of new indole derivatives, which hold significant potential for medical applications.

Latest Patents

Champseix's sole patent involves "Compositions containing new indole derivatives and their use in pharmacology." The innovative compositions he has explored are based on indole derivatives, which are recognized for their diverse biological activities. This patent represents a significant advancement in the pharmacological use of indole derivatives.

Career Highlights

Alain Andre Champseix works with Mar-pha Société D'études et D'exploitation de Marques, where he continues to explore new frontiers in pharmacological research. His work is characterized by a dedication to innovative solutions that address complex challenges in medicine.

Collaborations

Throughout his career, Champseix has collaborated with esteemed colleagues, including Claude G Gueremy and Gerard R Le Fur. These partnerships have enriched his research and expanded the impact of his innovations within the pharmaceutical industry.

Conclusion

Alain Andre Champseix exemplifies the spirit of innovation in pharmacology. His contributions, particularly through his patent on indole derivatives, reinforce the importance of continuous advancement in medical research and applications. As he collaborates with talented professionals, the future of his work promises exciting developments in the pharmacological landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…